Stock TENX TENAX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Tenax Therapeutics, Inc.

Equities

TENX

US88032L6056

Market Closed - Nasdaq
Other stock markets
 01:30:00 22/06/2024 am IST 		5-day change 1st Jan Change
2.77 USD -8.58% Intraday chart for Tenax Therapeutics, Inc. -11.78% -87.39%
14/05 Tenax Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
28/03 Tenax Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tenax Therapeutics, Inc. Appoints Lawrence R. Hoffman as Principal Financial Officer and Principal Accounting Officer
CI
Tenax Therapeutics, Inc. Appoints Javed Butler to its PH-HFpEF Scientific Advisory Board
CI
Tenax Therapeutics, Inc. Announces Resignation of Executives
CI
Tenax Therapeutics, Inc. Appoints Robyn Hunter to the Board of Directors
CI
Tenax Therapeutics : to 'Separate' From President and Chief Financial Officer Michael Jebsen Oct. 29
MT
Tenax Therapeutics, Inc. Announces Executive Changes
CI
Tenax Therapeutics, Inc. Announces Resignation of James Mitchum from the Board
CI
Tenax Therapeutics, Inc. Appoints Christopher T. Giordano to Serve as Director, Effective July 14, 2021
CI
Tenax Therapeutics, Inc. Announces Management Changes
CI
Tenax Therapeutics, Inc. Announces Board Changes
CI
Tenax Therapeutics, Inc. Expands Board of Directors
CI
Tenax Therapeutics, Inc. Appoints Stuart Rich as Chief Medical Officer
CI
Tenax Therapeutics, Inc. Announces Board Changes
CI
Tenax Therapeutics, Inc. Announces Addition of Barry Borlaug to Scientific Advisory Board
CI
Tenax Therapeutics, Inc. Announces Executive Changes
CI
Tenax Therapeutics, Inc. Appoints Stuart Rich, Daniel Burkhoff and Sanjiv Shah to Scientific Advisory Board
CI
Tenax Therapeutics, Inc. Announces Management Changes
CI
Tenax Therapeutics, Inc. Announces Nomination of James Mitchum to Board of Directors
CI
William Chatfield Announces Not to Stand for Re-Election as Director of Tenax Therapeutics, Inc
CI
Tenax Therapeutics, Inc. Appoints Paula Bokesch as Chief Medical Officer, Effective February 14, 2015
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TENX Stock
  4. News Tenax Therapeutics, Inc.
  5. Insiders